Pharmaceutical

STAT+: AbbVie CEO Gonzalez to step down after a decade ...

AbbVie CEO Richard Gonzalez has been a subject of nearly constant criticism, but...

Bayer, short on cash, reaches into shareholders’ pockets

German pharmaceutical giant Bayer is slashing its dividend by 95%, part of an on...

STAT+: Pharmalittle: We’re reading about weight loss dr...

China has more obese people than anywhere else in the world, and they are increa...

STAT+: A lawsuit over a controversial Sanofi drug short...

A U.S. appeals court revived a controversial lawsuit that alleged people were ha...

Phage therapy: Researchers sharpen another arrow in the...

With phage therapy, researchers sharpen another arrow in the quiver against anti...

Alabama hospital pauses IVF treatments in wake of rulin...

In the wake of the state court ruling on frozen embryos, the U. of Alabama, Birm...

Small study adds to growing hope CAR-T cell therapy cou...

People with autoimmune disorders don’t usually get to talk about a cure. But a s...

STAT+: Scientists take a (small) step toward universal ...

Scientists have laid out a blueprint for creating a “universal antivenom.”

STAT+: Pharmalittle: We’re reading about a CEO change a...

AbbVie announced that CEO Richard Gonzalez, who has managed its ascent since bei...

Actually Wegovy is good for dialysis companies, dialysi...

Why GLP-1 treatments like Wegovy could actually help dialysis companies, despite...

STAT+: DarioHealth acquires Twill, hoping it’s a shortc...

DarioHealth, with apps for managing chronic diseases, will acquire mental health...

NIH study of ME/CFS points to immune dysfunction and br...

A NIH study of myalgic encephalomyelitis, or chronic fatigue syndrome, points to...

Watch: What is in utero gene editing?

In utero gene editing envisions treating a fetus diagnosed with a genetic diseas...

Opinion: How Medicare leaves Puerto Ricans behind

Medicare funding should be distributed based on need, not unequal territorial st...

Meet the fetal surgeon forging CRISPR’s next frontier: ...

Tippi MacKenzie envisions doing surgery without scalpels or sutures, editing fet...

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihoo...

RioDerm-001 is under clinical development by Rion and currently in Phase II for ...